Concepedia
Statistics
Publications
6
Citations
719
H-Index
Active since
2012
Affiliations
Futaba (Japan)(Current)
Hokkaido University
Shionogi (Japan)
Kyoto University
Kyoto University Institute for Chemical Research
Koji Kasamatsu is an author at Futaba (Japan) specializing in medicinal chemistry, sars-cov-2 infection, and antiviral therapy.
Publications per year
2012–2023
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19
Yuto Unoh, Shota Uehara, Kenji Nakahara et al. · Journal of Medicinal Chemistry · 2022 · 590 citations · Full text
Medicine, Infectious Diseases, Pharmacology +15
Discovery of S-217622, a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19
Yuto Unoh, Shota Uehara, Kenji Nakahara et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2022 · 56 citations · Full text
Pharmacy, Infectious Diseases, Pharmacology +13
α-Arylation of α-Amino Acid Derivatives with Arynes via Memory of Chirality: Asymmetric Synthesis of Benzocyclobutenones with Tetrasubstituted Carbon
Koji Kasamatsu, Tomoyuki Yoshimura, Attila Mándi et al. · Organic Letters · 2017 · 28 citations
Natural Sciences, Chemistry, Medicinal Chemistry +15
Development of a Manufacturing Process toward the Convergent Synthesis of the COVID-19 Antiviral Ensitrelvir
Takahiro Kawajiri, Akihito Kijima, Atsuhiro Iimuro et al. · ACS Central Science · 2023 · 24 citations · Full text
Pharmacy, Chemistry, Medicinal Chemistry +17
(Z)-N-(4-Decenoyl)homoserine lactone, a new quorum-sensing molecule, produced by endobacteria associated with Mortierella alpina A-178
Kenji Kai, Koji Kasamatsu, Hideo Hayashi · Tetrahedron Letters · 2012 · 11 citations
Life Sciences, Biology, Microbiology +9
1–5 of 6